{"schema_version":"secwatch.filing_event.v1","accession":"0000310764-24-000095","form_type":"8-K","ticker":"SYK","cik":"0000310764","company_name":"STRYKER CORP","filed_at":"2024-07-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:15.468519+00:00","generated_at":"2026-05-31T15:28:48.141566+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Stryker Q2 2024: organic sales +9.0%, adj. EPS $2.81, raises FY guidance","bullets":["Net sales $5.4B (+8.5% reported, +9.0% organic); MedSurg Neuro +9.7% organic, Ortho Spine +8.0% organic.","Reported EPS $2.14 (+10.9% YoY); adjusted EPS $2.81 (+10.6% YoY); adjusted op. margin 24.6% (+30 bps).","FY 2024 organic sales growth guidance raised to 9.0%-10.0%; adjusted EPS guidance $11.90-$12.10.","Adjusted net earnings $1,085M (+11.2%). Guided for modest FX headwind ($0.10-$0.15) on adjusted EPS."],"urls":{"canonical":"https://secwatch.observer/filing/0000310764-24-000095","json":"https://secwatch.observer/filing/0000310764-24-000095.json","markdown":"https://secwatch.observer/filing/0000310764-24-000095.md","text":"https://secwatch.observer/filing/0000310764-24-000095.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/310764/000031076424000095/0000310764-24-000095-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/310764/000031076424000095/syk-20240730.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T15:28:48.141566+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}